The safety issue with the anti-inflammatory drug ‘Celecoxib’… what are doctors’ opinions?

Published: 2014-11-19 15:22:38

Updated: 2014-11-19 15:24:18

A COX-2 selective nonsteroidal anti-inflammatory drug ‘Celecoxib’ has got in a safety issue again.

The celecoxib’scardiovascular safety issue has received attention again in the last September 2 when the National Institute of Food and Drug Safety Evaluation (NIFDS) asked to change contents of permission.

Followed by an order of the NIFDS, Pfizer added the statement ‘In order to minimize poten...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.